Immuron Corporate Presentations

Corporate Presentations

Watch Coffee Microcaps Morning Meeting Webinar (November 2023) here
Watch the Immuron (ASX:IMC): Emerging ASX Gems presentation (November 2023) here
Download Immuron (ASX:IMC/NASDAQ:IMRN) AusBioInvest Presentation October 2023 here
Sign up for free & watch the Immuron (ASX:IMC/NASDAQ:IMRN) HCW Investor Presentation September 2023 here
Download Immuron (ASX:IMC/NASDAQ:IMRN) HCW Investor Presentation September 2023 here
Download Immuron (ASX:IMC/NASDAQ:IMRN) BIoshares Presentation July 2023 here
Download Immuron (ASX:IMC/NASDAQ:IMRN) Investor Presentation LD Micro June 2023 here
Watch the Immuron (ASX:IMC/NASDAQ:IMRN) Business Update April 2023 here
Download our full Immuron (ASX:IMC/NASDAQ:IMRN) Corporate Slide Deck April 2023 here
Immuron (ASX:IMC/NASDAQ:IMRN) Investor Presentation Coffee Microcaps May 2023 here

Immuron Ltd (ASX:IMC) (NASDAQ:IMRN) is a commercial and clinical stage publicly listed Australian biopharmaceutical company with a proprietary technology platform focused on the development and commercialization of a novel class of specifically targeted polyclonal antibodies.

The company presently has three drug candidates in clinical development and several in early stage preclinical development. Immuron believes its therapeutic drug candidates have the potential to transform the existing treatment paradigms for moderate to severe Campylobacteriosis, recurrent Clostridiodes difficile (C.difficle) infections, Enterotoxigenic Escherichia coli (ETEC) infections, Shigellosis (Bacillary dysentery) and travelers’ diarrhea.

Payment Options

Contact Information

Address: Building 10, 25-37 Chapman Street, Blackburn North, VIC 3131 Australia
Phone: +613 8892 4854
Fax: +613 9899 8533

Categories

Information

Corporate Presentations

Partners

Secure Shopping

Get Connected

About Us

Information

Payment Options

Contact Information